What is cbdMD?
Founded in 2015 and headquartered in North Carolina, cbdMD is a prominent manufacturer and provider of a diverse range of CBD-infused products. Their product portfolio includes CBD tinctures, capsules, gummies, topicals, bath bombs, and pet products, catering to a broad consumer base seeking wellness solutions. The company's strategic positioning in the burgeoning CBD market underscores its growth trajectory.
How much funding has cbdMD raised?
cbdMD has raised a total of $18.3M across 2 funding rounds:
Debt
$1M
Stock Offering
$17.3M
Debt (2020): $1M with participation from PPP
Stock Issuance/Offering (2020): $17.3M led by Undisclosed
Key Investors in cbdMD
Undisclosed Investors
PPP
Public-Private Partnership
Undisclosed Investors
What's next for cbdMD?
The recent major strategic investment indicates a pivotal phase for cbdMD, likely aimed at scaling operations, expanding market reach, and potentially developing new product lines. This infusion of capital is expected to bolster the company's competitive edge in the dynamic CBD industry, enabling further innovation and market penetration. The company's focus on a wide array of consumer and pet products suggests a strategy to capture diverse market segments.
See full cbdMD company page
